File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.14309/ctg.0000000000000196
- Scopus: eid_2-s2.0-85094684370
- WOS: WOS:000575994700002
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients
Title | Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients |
---|---|
Authors | |
Issue Date | 2020 |
Publisher | Nature Publishing Group: Open Access Journals - Option A. The Journal's web site is located at http://www.nature.com/ctg/index.html |
Citation | Clinical and Translational Gastroenterology, 2020, v. 11, p. article no. e00196 How to Cite? |
Abstract | INTRODUCTION:
Spontaneous hepatitis B surface antigen (HBsAg) seroclearance, the functional cure of hepatitis B infection, occurs rarely. Prior original studies are limited by insufficient sample size and/or follow-up, and recent meta-analyses are limited by inclusion of only study-level data and lack of adjustment for confounders to investigate HBsAg seroclearance rates in most relevant subgroups. Using a cohort with detailed individual patient data, we estimated spontaneous HBsAg seroclearance rates through patient and virologic characteristics.
METHODS:
We analyzed 11,264 untreated patients with chronic hepatitis B with serial HBsAg data from 4 North American and 8 Asian Pacific centers, with 1,393 patients with HBsAg seroclearance (≥2 undetectable HBsAg ≥6 months apart) during 106,192 person-years. The annual seroclearance rate with detailed categorization by infection phase, further stratified by hepatitis B e antigen (HBeAg) status, sex, age, and quantitative HBsAg (qHBsAg), was performed.
RESULTS:
The annual seroclearance rate was 1.31% (95% confidence interval: 1.25–1.38) and over 7% in immune inactive patients aged ≥55 years and with qHBsAg <100 IU/mL. The 5-, 10-, 15-, and 20-year cumulative rates were 4.74%, 10.72%, 18.80%, and 24.79%, respectively. On multivariable analysis, male (adjusted hazard ratio [aHR] = 1.66), older age (41–55 years: aHR = 1.16; >55 years: aHR = 1.21), negative HBeAg (aHR = 6.34), and genotype C (aHR = 1.82) predicted higher seroclearance rates, as did lower hepatitis B virus DNA and lower qHBsAg (P < 0.05 for all), and inactive carrier state.
DISCUSSION:
The spontaneous annual HBsAg seroclearance rate was 1.31%, but varied from close to zero to about 5% among most chronic hepatitis B subgroups, with older, male, HBeAg-negative, and genotype C patients with lower alanine aminotransferase and hepatitis B virus DNA, and qHBsAg independently associated with higher rates (see Visual Abstract, Supplementary Digital Content 2, http://links.lww.com/CTG/A367). |
Persistent Identifier | http://hdl.handle.net/10722/304488 |
ISSN | 2023 Impact Factor: 3.0 2023 SCImago Journal Rankings: 1.413 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yeo, YH | - |
dc.contributor.author | Tseng, TC | - |
dc.contributor.author | Hosaka, T | - |
dc.contributor.author | Cunningham, C | - |
dc.contributor.author | Fung, JYY | - |
dc.contributor.author | Ho, HJ | - |
dc.contributor.author | Kwak, MS | - |
dc.contributor.author | Trinh, HN | - |
dc.contributor.author | Ungtrakul, T | - |
dc.contributor.author | Yu, ML | - |
dc.contributor.author | Kobayashi, M | - |
dc.contributor.author | Le, AK | - |
dc.contributor.author | Henry, L | - |
dc.contributor.author | Li, J | - |
dc.contributor.author | Zhang, J | - |
dc.contributor.author | Sriprayoon, T | - |
dc.contributor.author | Jeong, D | - |
dc.contributor.author | Tanwandee, T | - |
dc.contributor.author | Gane, E | - |
dc.contributor.author | Cheung, RC | - |
dc.contributor.author | Wu, CY | - |
dc.contributor.author | Lok, AS | - |
dc.contributor.author | Lee, HS | - |
dc.contributor.author | Suzuki, F | - |
dc.contributor.author | Yuen, MF | - |
dc.contributor.author | Kao, JH | - |
dc.contributor.author | Yang, HI | - |
dc.contributor.author | Nguyen, MH | - |
dc.date.accessioned | 2021-09-23T09:00:44Z | - |
dc.date.available | 2021-09-23T09:00:44Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Clinical and Translational Gastroenterology, 2020, v. 11, p. article no. e00196 | - |
dc.identifier.issn | 2155-384X | - |
dc.identifier.uri | http://hdl.handle.net/10722/304488 | - |
dc.description.abstract | INTRODUCTION: Spontaneous hepatitis B surface antigen (HBsAg) seroclearance, the functional cure of hepatitis B infection, occurs rarely. Prior original studies are limited by insufficient sample size and/or follow-up, and recent meta-analyses are limited by inclusion of only study-level data and lack of adjustment for confounders to investigate HBsAg seroclearance rates in most relevant subgroups. Using a cohort with detailed individual patient data, we estimated spontaneous HBsAg seroclearance rates through patient and virologic characteristics. METHODS: We analyzed 11,264 untreated patients with chronic hepatitis B with serial HBsAg data from 4 North American and 8 Asian Pacific centers, with 1,393 patients with HBsAg seroclearance (≥2 undetectable HBsAg ≥6 months apart) during 106,192 person-years. The annual seroclearance rate with detailed categorization by infection phase, further stratified by hepatitis B e antigen (HBeAg) status, sex, age, and quantitative HBsAg (qHBsAg), was performed. RESULTS: The annual seroclearance rate was 1.31% (95% confidence interval: 1.25–1.38) and over 7% in immune inactive patients aged ≥55 years and with qHBsAg <100 IU/mL. The 5-, 10-, 15-, and 20-year cumulative rates were 4.74%, 10.72%, 18.80%, and 24.79%, respectively. On multivariable analysis, male (adjusted hazard ratio [aHR] = 1.66), older age (41–55 years: aHR = 1.16; >55 years: aHR = 1.21), negative HBeAg (aHR = 6.34), and genotype C (aHR = 1.82) predicted higher seroclearance rates, as did lower hepatitis B virus DNA and lower qHBsAg (P < 0.05 for all), and inactive carrier state. DISCUSSION: The spontaneous annual HBsAg seroclearance rate was 1.31%, but varied from close to zero to about 5% among most chronic hepatitis B subgroups, with older, male, HBeAg-negative, and genotype C patients with lower alanine aminotransferase and hepatitis B virus DNA, and qHBsAg independently associated with higher rates (see Visual Abstract, Supplementary Digital Content 2, http://links.lww.com/CTG/A367). | - |
dc.language | eng | - |
dc.publisher | Nature Publishing Group: Open Access Journals - Option A. The Journal's web site is located at http://www.nature.com/ctg/index.html | - |
dc.relation.ispartof | Clinical and Translational Gastroenterology | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.title | Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients | - |
dc.type | Article | - |
dc.identifier.email | Fung, JYY: jfung@hkucc.hku.hk | - |
dc.identifier.email | Yuen, MF: mfyuen@hku.hk | - |
dc.identifier.authority | Fung, JYY=rp00518 | - |
dc.identifier.authority | Yuen, MF=rp00479 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.14309/ctg.0000000000000196 | - |
dc.identifier.scopus | eid_2-s2.0-85094684370 | - |
dc.identifier.hkuros | 325492 | - |
dc.identifier.volume | 11 | - |
dc.identifier.spage | article no. e00196 | - |
dc.identifier.epage | article no. e00196 | - |
dc.identifier.isi | WOS:000575994700002 | - |
dc.publisher.place | United States | - |